An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
This study was registered inClinicalTrials.gov– identifier NCT04750395 (Source: Trials)
Source: Trials - April 14, 2022 Category: Research Source Type: clinical trials
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Conditions: Schizophrenia; Bipolar I Disorder Interventions: Drug: OLZ/SAM; Drug: Olanzapine Sponsor: Alkermes, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials